title: [Breast cysts].
abstract: The mammary cyst is part of the fibro-cystic disease. Only cysts with a diameter of more than 3 mm would have a pathological significance. Its clinical symptomatology is well known. The clearing puncture is the essential diagnostic and therapeutic act. Mammography, sustained by cystography, furnishes highly worthy information. Thermography and ultra-sonography may also be useful. Its pathogeny is still being very much discussed. Hormonal factors are incriminated: hyperestrogenemia, luteal deficiency, dysprolactinemia are inconstant. They are neither necessary nor sufficient to induce the cystic disease. The titration of TeBG may perhaps open an interesting path for research. The study of intracystic steroids (among which DHEAS) furnishes instructive results. Intracystic glycoproteins, proteins and electrolytes are also the objects of promising research. Recently, the interest lying in the study of EGF, its possible relation to DHEAS and the intracystic Na/K ratio were emphasized. It is also important to notice the presence of cysts with a flat wall or with a hyperplastic wall, of the apocrine type. The psychogenic factors seem to be determining in the cystic flare-ups. The relations with breast cancer remain the fundamental problem. Although the cyst itself only exceptionally degenerates into cancer (cyst-epithelioma), the very presence of a macrocytic disease multiplies by 3 or 4 the risk of cancer. The treatment is composed of psychotherapy, tranquillizers and a clearing puncture of the strained cysts. The administration of phlebotonics, anti-prostaglandins, colostrum extracts, can give substantial results. The author gives details about the part of hormonal treatment as a function of the titrations and the severity of the case. If it appears necessary to block the gonadotropic function, Danazol is a very effective agent. Surgery has but a small place. Indication of subcutaneous mastectomy will rest upon a very severe case-selection.
authors.affiliation: Centre des Maladies du Sein, Hôpital Saint-Louis, Paris.
authors.forename: A
authors.initials: A
authors.lastname: Gorins
authors.forename: B
authors.initials: B
authors.lastname: Tournant
authors.forename: F
authors.initials: F
authors.lastname: Perret
authors.forename: H
authors.initials: H
authors.lastname: Degrelle
authors.forename: K
authors.initials: K
authors.lastname: Nahoul
authors.forename: M L
authors.initials: ML
authors.lastname: Kottler
mesh_terms: D000293:Adolescent; D001943:Breast Neoplasms / Q000175:diagnosis; D003937:Diagnosis, Differential; D003952:Diagnostic Imaging; D004815:Epidermal Growth Factor / Q000378:metabolism; D005260:Female; D005348:Fibrocystic Breast Disease / Q000175:diagnosis* / Q000378:metabolism / Q000628:therapy; D006728:Hormones / Q000378:metabolism; D006801:Humans; D008875:Middle Aged
chemical_list: D006728:Hormones; D004815:Epidermal Growth Factor
vernacular_title: Les kystes mammaires.